"Frank Woodson is an important member of the team (Mass Torts), and has been influential in Zyprexa and Vioxx litigation."

- The Legal 500 quote, 2008 edition

"Frank Woodson, considered by many to be Birchfield's "right hand man", maintains a multi-faceted practice that sees him active in a variety of cases, including Vioxx litigation, and has recently been at the forefront of the firm's Zyprexa caseload.  In addition, he has emerged as the firm's go-to attorney for claims related to Stevens-Johnson syndrome."

- The Legal 500 quote, 2007 edition

Frank was a former partner in the general litigation firm of Turner, Onderdonk, Kimbrough & Howell in Mobile, Alabama, where his practice focused on litigation, both plaintiff and defense. Examples of the type of plaintiff’s litigation he handled included: consumer fraud cases against car dealers, finance fraud involving door-to-door sales, personal injury litigation and obtaining landowners' just compensation when their property was taken in eminent domain proceedings.

Frank joined Beasley Allen in 2001, and his practice focuses on Mass Torts related to pharmaceuticals. He has brought seventeen years of litigation experience to the Mass Torts Section. Frank is involved in the firm's COX-2 drug litigation. He is a frequent speaker at seminars including  a "Mass Torts Made Perfect" seminar in New York City on Vioxx; an ATLA teleseminar entitled, "Pain Killers and the FDA";  another Vioxx seminar in Jackson,Mississippi and recently speaking at local seminars in Alabama on preemption.

His most recent litigation is on behalf of clients who suffer from severe injury to their shoulder joint as a result of the use of a pain pump after shoulder surgery. Frank is working with law firms in Oregon who discovered the problems with these pain pumps. One case was settled in the fall of 2008 and another is scheduled for trial in February 2009 in Portland,Oregon. To learn about this litigation you can visit the pain pump section of the Beasley Allen website.

Beginning in 2005, Frank served as the Vice Chairman of the sales and marketing committee for the Vioxx MDL in New Orleans. Frank participated in several of the firm’s Vioxx trials. He lead a team of lawyers who prepared video deposition cuts for several Vioxx trials as well as other aspects of a Vioxx MDL trial package. Much of the evidence presented at the MDL trials were through video depositions.

Frank was appointed to the Plaintiff Steering Committee for theBextra/Celebrex MDL in San Francisco in 2007. In preparation for the first trial in the MDL, Frank was asked to lead another team of lawyers to prepare the video deposition cuts which requires many hours negotiating with defense counsel and providing a transcript the MDL court for ruling on objections far in advance of the trial. He is currently working on the evaluation and possible resolution of the firms Bextra and Celebrex claims.

Frank’s staff has worked diligently over the past 3 years to gain some compensation for the firm’s Zyprexa clients. The clients claims were evaluated according to objective standards to determine whether they qualified for payment and how much that would be. Compensation has begun to be paid to clients in late 2008 and the remainder of the clients should be compensated in 2009.

Frank was responsible for preparing the firm's first Rezulin case for trial that helped generate the first group settlement of Rezulin cases in the country. In the spring of 2002 he was also involved in the additional group settlements of the firms Rezulin cases in the Fall of 2002 and the Spring of 2003, culminating in all the firm's Rezulin cases being resolved in 2004. The amounts of the Rezulin settlements are all confidential.

As a part of the Mass Tort section's Baycol team beginning in 2001. He was a frequent speaker on this litigation, having spoken at the 2002 ATLA Convention in Atlanta, the Baycol “Hot Doc’s” Seminar in Phoenix and on the first live Internet seminar broadcast live for plaintiffs attorneys held in Newark, N.J. Frank was responsible for taking several key depositions in this national litigation. He has worked on the settlement of most of the firm's Baycol cases resulting in settlements in excess of $70 million.

Frank enrolled all of the firm’s 10,000 Propulsid claims in the MDL settlement program. The program is ongoing and several clients have been awarded settlements in this litigation. Frank represented a group of claimants who suffered various injuries from a rheumatoid arthritis medication that were resolved after extensive workup and negotiation.

Frank has handled several cases that were not mass torts. He filed a lawsuit alleging Neurontin caused the client to commit suicide and is investigating claims involving drugs that cause Stevens Johnson Syndrome(SJS), having resolved claims for two clients who were blinded by SJS. In late 2008 he worked to resolve a claim for a child who required a liver transplant after ingestion of an antibiotic. He currently represents the family of another child who died from liver failure after ingestion of an antibiotic.  He has been instrumental in resolving other pharmaceutical litigation on a confidential basis, which were not mass torts.

Frank is a former president of Mobile County Young Lawyers and was also a member of Mobile County Bar Association Executive Committee and of the State of Alabama Young Lawyers Committee. In addition, he currently serves as a Trustee on the Executive Committee of the Alabama Association for Justice. Frank is the author of "Pharmaceutical Drug Litigation - An Overview", "The Bayer Criminal Convictions" and recently “Forget Tort reform, we want Immunity.”

Frank is married to the former Marti Glaze of Tuscaloosa, Alabama, and they have four children. The family are active members of Frazer United Methodist Church, where Frank served on the Board of Stewards, is a member of the Harbor Light Sunday school class and serves as an Usher in the contemporary service.